Видео с ютуба Esr1 Mutation

Breast Cancer Breakthroughs: The Importance of ESR1 mutations in metastatic breast cancer

ELAINE 1: ESR1 mutations in ctDNA from ER+/HER2- mBC treated with lasofoxifene or fulvestrant

Understanding Progression: How to Identify and Treat ESR1 Mutations in HR+ MBC

ESR1 Mutation: The Need for & Role of Testing in ER+/ HER2- Advanced or Metastatic Breast Cancer

Dr. Fuqua on ESR1 Mutations in Primary Breast Cancer

SABCS 2021: "Transcriptional reprogramming, ESR1 mutations, and novel targets and treatment"

Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcomes in HR+ Advanced Breast Cancer

ESR1 mutation in untreated EC: prevalence, characteristics and prognosis from the UTOLA trial

ESR1 testing guides treatment in metastatic breast cancer

ESR1 Mutations in Breast Cancer | Insights from Dr Wassim Mchayleh

ESR1 Mutations in Metastatic Breast Cancer: Should I get tested?

Dr. Goncalves Describes Research Involving the ESR1 Mutation in Breast Cancer

Dr. Tolaney on Presence of PIK3CA and ESR1 Mutations in MONARCH 2 Trial in Breast Cancer

Understanding ESR1 Mutations in HR+, HER2- Metastatic Breast Cancer

New Horizons in ESR1-Mutated Breast Cancer

ESR1 Mutations in Focus: Are PROTACs the Next Breakthrough?

Treatment Options for Patients with ESR1 Mutated Breast Cancer after CDK4/6i Progression

Unlocking ESR1 Mutations in Breast Cancer

Dr. Goetz on Treatment Challenges for ESR1-Mutant Breast Cancer

ESR1 Mutated Metastatic Breast Cancer Market Size was ~USD 800 Million in 2022